Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H BAIRD

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Transplantation and Cellular Therapy|January 12, 2026
Impact of Complete Response on Long-Term Survival in Patients With Relapsed or Refractory Large B-cell Lymphoma: A CIBMTR Prospective Study and SLR/Meta-AnalysisArmin Ghobadi, Theodora Anagnostou, Jacques Azzi, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2013
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cellsMark A Currier, Francis K Eshun, Allyson Sholl, et al.
Lancet (London, England)|July 12, 2024
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 studyMatthew J Frank, John H Baird, Anne Marijn Kramer, et al.
American Journal of Cancer Research|September 15, 2025
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysisLori A Leslie, John H Baird, Ian W Flinn, et al.
Blood Advances|October 8, 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetrationLei Gao, Avyakta Kallam, Geoffrey Shouse, et al.
Blood Advances|February 11, 2021
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphomaJohn H Baird, David J Epstein, John S Tamaresis, et al.
Ecology|March 7, 2023
Six years of demography data for 11 reef coral speciesJoshua S Madin, Andrew H Baird, Sean R Connolly, et al.
Cancer Discovery|January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCLYi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Global Change Biology|September 1, 2019
Refugia under threat: Mass bleaching of coral assemblages in high-latitude eastern AustraliaSun W Kim, Eugenia M Sampayo, Brigitte Sommer, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Transplantation and Cellular Therapy|January 12, 2026
Impact of Complete Response on Long-Term Survival in Patients With Relapsed or Refractory Large B-cell Lymphoma: A CIBMTR Prospective Study and SLR/Meta-AnalysisArmin Ghobadi, Theodora Anagnostou, Jacques Azzi, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2013
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cellsMark A Currier, Francis K Eshun, Allyson Sholl, et al.
Lancet (London, England)|July 12, 2024
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 studyMatthew J Frank, John H Baird, Anne Marijn Kramer, et al.
American Journal of Cancer Research|September 15, 2025
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysisLori A Leslie, John H Baird, Ian W Flinn, et al.
Blood Advances|October 8, 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetrationLei Gao, Avyakta Kallam, Geoffrey Shouse, et al.
Blood Advances|February 11, 2021
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphomaJohn H Baird, David J Epstein, John S Tamaresis, et al.
Ecology|March 7, 2023
Six years of demography data for 11 reef coral speciesJoshua S Madin, Andrew H Baird, Sean R Connolly, et al.
Cancer Discovery|January 8, 2025
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCLYi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, et al.
Global Change Biology|September 1, 2019
Refugia under threat: Mass bleaching of coral assemblages in high-latitude eastern AustraliaSun W Kim, Eugenia M Sampayo, Brigitte Sommer, et al.
Pageof 21